In addition, loss of ERα expression in lymphatic metastasis was also positively associated with the clinical stage (P=0.007), the number of lymph node metastases (P=0.011) and the loss of progesterone receptor expression (P=0.045). The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.